Investing Profile

Robert Nelsen

VCInvestor

Co-founder and a Managing Director of ARCH Venture Partners

Photo of Robert Nelsen, Managing Director at ARCH Venture Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
ARCH Venture Partners Managing Director
$50K - $150.0M
$75.0M
73
$635.8M
CompanyStageDateRound SizeTotal Raised
Katalyst
Series AOct 2022$26M
$32M
Co-investors: Jo Oliver (Octopus Ventures)
Rippl Care
Seed RoundSep 2022$32M
$32M
Co-investors: Holly Maloney McConnell (General Catalyst)
Vilya
Series AAug 2022$50M
$50M
Homeward
Series BAug 2022$50M
$230M
Co-investors: Hemant Taneja (General Catalyst), Lee Shapiro (7wire Ventures), Jed Katz (Javelin Venture Partners), Jeff Crowe (Norwest Venture Partners)
Be Biopharma
Series BApr 2022$130M
$130M
Recuro Health
Convertible NoteMar 2022
Series AAug 2021$15M
$15M
Co-investors: Mike Moradi
LifeMine Therapeutics
Series CMar 2022$180M
Series ASep 2017$70M
$250M
Co-investors: Krishna Yeshwant (GV), Jim Tananbaum (Foresite Capital)
Nutcracker Therapeutics
Series CMar 2022$170M
Series BSep 2020$60M
$230M